Biofrontera (BFRI) Cash & Current Investments (2020 - 2026)

Biofrontera's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $6.4 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 8.41% year-over-year to $6.4 million; the TTM figure through Dec 2025 stood at $6.4 million (up 8.41% YoY), while the FY2025 annual figure was $6.4 million, up 8.41% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $6.4 million, up from $3.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $31.9 million in Q2 2022, with the low at $1.4 million in Q4 2023.
• The 5-year median for Cash & Current Investments is $6.4 million (2025), against an average of $11.1 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 1502.56% in 2022, then plunged 94.88% in 2023.
• Biofrontera's Cash & Current Investments stood at $24.5 million in 2021, then grew by 13.29% to $27.8 million in 2022, then slumped by 94.88% to $1.4 million in 2023, then surged by 316.05% to $5.9 million in 2024, then advanced by 8.41% to $6.4 million in 2025.
• Business Quant data shows BFRI's Cash & Current Investments at $6.4 million in Q4 2025, $3.4 million in Q3 2025, and $7.2 million in Q2 2025.